Abstract
The aim of this paper was to critically review the current treatment of anxiety disorders including general anxiety disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder. For all these disorders, this paper will suggest treatment guidelines based on literature data as well as personal experience. Obsessive compulsive disorder (OCD) even considered in DSM IV as an anxiety disorder is somewhere different from the other anxiety disorder (almost lack of placebo response, efficacy of cognitive- behavioural therapy and deep brain stimulation).
Keywords: Benzodiazepines, serotonin selective reuptake inhibitors (SSRIs), antidepressants, generalized anxiety disorder (GAD), panic disorder (PD), social anxiety disorder (SAD), post traumatic stress disorder (PTSD).
Current Psychopharmacology
Title:A Critical Approach of the Current Treatment of Anxiety Disorders
Volume: 2
Author(s): Michel Bourin and Florence Thibaut
Affiliation:
Keywords: Benzodiazepines, serotonin selective reuptake inhibitors (SSRIs), antidepressants, generalized anxiety disorder (GAD), panic disorder (PD), social anxiety disorder (SAD), post traumatic stress disorder (PTSD).
Abstract: The aim of this paper was to critically review the current treatment of anxiety disorders including general anxiety disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder. For all these disorders, this paper will suggest treatment guidelines based on literature data as well as personal experience. Obsessive compulsive disorder (OCD) even considered in DSM IV as an anxiety disorder is somewhere different from the other anxiety disorder (almost lack of placebo response, efficacy of cognitive- behavioural therapy and deep brain stimulation).
Export Options
About this article
Cite this article as:
Bourin Michel and Thibaut Florence, A Critical Approach of the Current Treatment of Anxiety Disorders, Current Psychopharmacology 2013; 2 (2) . https://dx.doi.org/10.2174/2211556011302020002
DOI https://dx.doi.org/10.2174/2211556011302020002 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Basic and Clinical Aspects of Gene Therapy for Retinopathy Induced by Diabetes
Current Gene Therapy A Systematic Review of Drugs in Late-Stage Development for the Treatment of Multiple Sclerosis: A Focus on Oral Synthetic Drugs
Inflammation & Allergy - Drug Targets (Discontinued) 25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome—Unaltered in Young and not Correlated to Carotid IMT in All Ages
Current Pharmaceutical Design The GNAS Locus: Quintessential Complex Gene Encoding Gsα, XLαs, and other Imprinted Transcripts
Current Genomics Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells
Current Cancer Therapy Reviews Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design The Ubiquitous Choline Transporter SLC44A1
Central Nervous System Agents in Medicinal Chemistry The Renin-Angiotensin System: Emerging Concepts
Current Hypertension Reviews Rheumatoid Foot and Ankle Surgery
Current Rheumatology Reviews An Overview of Galenic Preparation Methods for Medicinal Cannabis
Current Bioactive Compounds A Girl with 10 Mb Distal Xp Deletion Arising from Maternal Pericentric Inversion: Clinical Data and Molecular Characterization
Current Genomics Aldehyde Dehydrogenase as a Marker for Stem Cells
Current Stem Cell Research & Therapy Editorial (Thematic Issue: Epigenetic Regulation and Human Diseases)
Current Pharmaceutical Design The HIV Entry Inhibitors Revisited
Current Medicinal Chemistry Allosteric Modulation of the Calcium-Sensing Receptor
Current Neuropharmacology Novel and Emerging Drugs for Rarer Chronic Lymphoid Leukaemias
Current Cancer Drug Targets Non-Pharmacological Treatments in Autism Spectrum Disorders: An Overview on Early Interventions for Pre-Schoolers
Current Clinical Pharmacology The Vitamin D/CYP24A1 Story in Cancer
Anti-Cancer Agents in Medicinal Chemistry Treatment of Insulin Resistance in the Neurodegeneration
Recent Patents on CNS Drug Discovery (Discontinued) Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children
Current Drug Metabolism